Clinical Data

Studies continue to support the RenovoCath for targeted treatment of pancreatic cancer. Following are highlights from journals and industry presentations.

Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter System <small><i>Journal of Vascular & Interventional Radiology<i>, September 2018</i></i></small>

Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter System Journal of Vascular & Interventional Radiology, September 2018

Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. <small><i>Journal of Pancreatic Cancer</i>, August 2017</small>

Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. Journal of Pancreatic Cancer, August 2017

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors. <small><i>Presented at AHPBA Annual Meeting</i>, April 2, 2017</small>

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors. Presented at AHPBA Annual Meeting, April 2, 2017

Pancreatic Cancer: Chemoembolization Using A Double Balloon Catheter. <small><i>Presented at AIM Symposium</i>, November 14, 2016</small>

Pancreatic Cancer: Chemoembolization Using A Double Balloon Catheter. Presented at AIM Symposium, November 14, 2016

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors. <small><i>Poster presented to 50th Annual Pancreas Club Meeting</i>, May 20-21, 2016</small>

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors. Poster presented to 50th Annual Pancreas Club Meeting, May 20-21, 2016

<small><i>Pancreas Club Abstract</i></small>: Is Intra-Arterial with Targeted Delivery of Gemcitabine Safe in Treatment of Patients with Loco-Regional Pancreatic Tumors? <small>May 20-21, 2016</small>

Pancreas Club Abstract: Is Intra-Arterial with Targeted Delivery of Gemcitabine Safe in Treatment of Patients with Loco-Regional Pancreatic Tumors? May 20-21, 2016

<small><i>IHPBA 2016 Abstract</i></small>: Intra-arterial and Tumor-Targeted Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer, <small>April 20-23, 2016</small>

IHPBA 2016 Abstract: Intra-arterial and Tumor-Targeted Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer, April 20-23, 2016

Menu